OTC
DEA Schedule CIII

Strength

10; 100; 30 mg/5mL; mg/5mL; mg/5mL

NDC

54859052016

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

7/20/2016

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/1/1995

Pharmacological Classes

Adrenergic alpha-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Full Opioid Agonists
Increased Respiratory Secretions
Opioid Agonist
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-1.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.